Find uplifting stories about heroes, innovations, and solutions
4 results for "psychedelic research"
Scientists discovered that one dose of psilocybin, the compound in magic mushrooms, can create measurable changes in brain structure that last at least a month. The findings could explain why psychedelics show promise in treating depression, anxiety, and addiction.
President Trump will sign an executive order Saturday to advance research into psychedelics like psilocybin and ibogaine for therapeutic use. The move could open doors for controlled access to these promising mental health treatments.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
Brazilian scientists discovered that one dose of the psychedelic DMT reversed depression symptoms in stressed mice better than 30 days of daily antidepressants. The breakthrough could lead to faster-acting treatments for severe depression.